IRF7 and systemic sclerosis: Rezaei R analyzed the methylation status of CpG sites of the IRF7 promoter in peripheral blood mononuclear cells (PBMCs) of systemic sclerosis (SSc) patients and found that hypomethylated CpG2 was associated with increased disease risk (43).